OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drop combo may offer Round-the-Clock glaucoma relief
Disease control Recruiting nowThis study tests whether a combination eye drop (Rocklatan) works better than a standard drop (Latanoprost) at lowering eye pressure over a full 24-hour period in adults with open-angle glaucoma or ocular hypertension. About 30 participants will use one drop in each eye nightly. …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:36 UTC
-
Eye implant could replace daily drops for glaucoma patients having cataract surgery
Disease control Recruiting nowThis study tests whether a tiny implant that releases medication inside the eye can control eye pressure as well as standard eye drops in people with glaucoma or high eye pressure who are also having cataract surgery. About 400 adults will receive either the implant plus a specia…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Glaucoma patients may get pressure relief along with cataract surgery
Disease control Recruiting nowThis study tests whether a tiny implant that releases eye-pressure-lowering medicine, placed during cataract surgery, works better than standard eye drops. About 400 adults with mild-to-moderate glaucoma or high eye pressure who need cataract surgery will take part. The goal is t…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Laser zaps eye drops: new study aims to cut glaucoma medication burden
Disease control Recruiting nowThis study tests a laser treatment called DSLT in 60 adults with glaucoma or high eye pressure who currently use 1-3 eye drops to keep their eye pressure under control. The goal is to see if the laser can reduce or eliminate the need for daily eye drops while still keeping eye pr…
Matched conditions: OCULAR HYPERTENSION
Sponsor: The Eye Institute of West Florida • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New eye drop aims to lower pressure in glaucoma patients
Disease control Recruiting nowThis study tests a new eye drop called HUC3-637 in 206 adults with primary open-angle glaucoma or ocular hypertension. The goal is to see if it safely lowers eye pressure better than an existing treatment. Participants will use the drops for a period and have their eye pressure m…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Huons Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Smart contact lens could replace eye pokes for glaucoma patients
Diagnosis Recruiting nowThis study tests a special contact lens that measures eye pressure continuously for 24 hours, compared to the standard method that only gives a quick reading. It involves 12 adults with open-angle glaucoma or high eye pressure. The goal is to see if the lens is accurate and comfo…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: Sensimed AG • Aim: Diagnosis
Last updated May 26, 2026 03:32 UTC
-
AI-Powered eye tests could catch glaucoma early in underserved communities
Diagnosis Recruiting nowThis study is testing whether an AI-assisted eye screening program at community health centers can help detect glaucoma and other eye conditions early. About 1,800 adults at higher risk for eye disease will receive a quick screening using AI tools. Researchers will compare detect…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated May 26, 2026 03:05 UTC
-
Eye implant may ease Drop-Related irritation in glaucoma patients
Knowledge-focused Recruiting nowThis study looks at whether switching from daily glaucoma eye drops to a long-lasting injectable implant (Durysta) can reduce inflammation on the eye's surface. Researchers will measure a marker of inflammation called caspase-1 in 20 adults with open-angle glaucoma or ocular hype…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE4 • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC